•   
  •   

UK News New Study Finds Hydroxychloroquine Did Not Prevent Covid-19

07:40  04 june  2020
07:40  04 june  2020 Source:   msn.com

Madagascar to send troops to town where two died of coronavirus

  Madagascar to send troops to town where two died of coronavirus Madagascar's government has announced it will dispatch troops and doctors to an eastern town after several bodies were found in the streets and where two people died from the novel coronavirus. Madagascar's cabinet held a special meeting on Sunday to discuss the situation in Toamasina, the country's second largest city. The Indian Ocean island nation has registered 527 infections and two deaths, both in Toamasina. Since Thursday, more than 120Madagascar's cabinet held a special meeting on Sunday to discuss the situation in Toamasina, the country's second largest city.

Health|Malaria Drug Promoted by Trump Did Not Prevent Covid Infections, Study Finds . The malaria drug hydroxychloroquine did not prevent Covid - 19 in a rigorous study of 821 people who had been exposed to patients infected with the virus, researchers from the University of Minnesota

In Preventing COVID - 19 , Study Finds : Shots - Health News A study of more than 800 health workers, first Taking hydroxychloroquine after being exposed to someone with COVID - 19 does not protect As Rajasingham and her colleagues report in the New England Journal of Medicine, 107 of

(Video by Reuters)

The malaria drug hydroxychloroquine did not prevent Covid-19 in a rigorous study of 821 people who had been exposed to patients infected with the virus, researchers from the University of Minnesota and Canada are reporting on Wednesday.

The study was the first large controlled clinical trial of hydroxychloroquine, a drug that President Trump has repeatedly promoted and recently taken himself. Conducted in the United States and Canada, this trial was also the first to test whether the drug could prevent illness in people who have been exposed to the coronavirus.

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

  WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns , WHO Director General Tedros Adhanom Ghebreyesus said on Monday.Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The U.S. President has said he was taking the drug to help prevent infection. Hydroxychloroquine sits on a shelf at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020. - US President Donald Trump announced May 18 he has been taking hydroxychloroquine for almost two weeks as a preventative measure against COVID-19.

Hydroxychloroquine did not prevent healthy people exposed to covid - 19 from getting the disease caused by the coronavirus, according to a study being published Wednesday in the New England Journal of Medicine. The study is the first randomized clinical trial that tested the antimalarial drug

A new study -- the largest of its kind -- shows that hydroxychloroquine , the drug touted by President Trump, does not work against Covid - 19 and could cause heart problems.

Sign Up For the Morning Briefing Newsletter

This type of study, in which patients are picked at random to receive either an experimental treatment or a placebo, is considered the most reliable way to measure the safety and effectiveness of a drug. The participants were health care workers and people who had been exposed at home to ill spouses, partners or parents.

“The take-home message for the general public is that if you’re exposed to someone with Covid-19, hydroxychloroquine is not an effective post-exposure preventive therapy,” the lead author of the study, Dr. David R. Boulware, from the University of Minnesota, said in an interview.

Boxes of hydroxychloroquine in a hospital pharmacy in Porto Alegre, Brazil. The Trump administration said Sunday it had sent 2 million doses of the drug to Brazil. © Diego Vara/Reuters Boxes of hydroxychloroquine in a hospital pharmacy in Porto Alegre, Brazil. The Trump administration said Sunday it had sent 2 million doses of the drug to Brazil.

The results were published in The New England Journal of Medicine.

These Are the Dirtiest Areas in Your Home You Need to Disinfect

  These Are the Dirtiest Areas in Your Home You Need to Disinfect As you try to keep your home safe and coronavirus-free, you may be missing some key places. Here's where you need to disinfect in your house ASAP.

Now, a new study will test whether the drug can prevent COVID - 19 transmission. For the study , researchers in New York and Washington state plan to Participants will be randomly assigned to take either hydroxychloroquine or a placebo for two weeks, and they will be tested daily for COVID - 19

hydroxychloroquine to prevent Covid - 19 infection.Credit Doug Mills/The New York Times. petri dishes do not always work in the human body, and studies of hydroxychloroquine have found that it A study from China did include a control group and suggested that hydroxychloroquine might

“If we could find something that would ameliorate infection, block it or make it milder after a solid exposure, that would be quite wonderful,” said Dr. Judith Feinberg, the vice chairwoman for research in medicine at West Virginia University. “What we want to do is limit the number of cases. There was great hope riding on this.”

____________________________________________________

More on coronavirus:

Download the Microsoft News app for full coverage of the crisis

Key changes to the UK's lockdown rules (The Guardian)

What the NHS Test and Trace system asks you to do (The Independent)

____________________________________________________

The president’s promotion of the drug, and the backlash against it, have politicized medical questions that would normally have been left to researchers to answer objectively. Trump supporters and opponents have accused one another of twisting facts about the drug to make the president look either right or wrong.

How to spec a Citroën Berlingo

  How to spec a Citroën Berlingo Our guide to Citroën's spacious MPV covers which options to pick, which to avoid and how much to pay for it all

A study published in the New England Journal of Medicine has shown that hydroxychloroquine does not “While we are disappointed that this did not prevent COVID - 19 , we are pleased that we were able The survey outcomes have found little support in US President Donald Trump's opinion on the

The study published on Friday found Covid - 19 patients who received the malaria drug were dying at higher rates and experiencing more heart-related complications than other virus patients. The large observational study analysed data from nearly 15,000 patients with Covid - 19 who received the drug

Regardless, Mr. Trump has not stopped touting the drug’s potential benefits. On Sunday, his administration announced that it was sending 2 million doses of the drug to Brazil, to treat patients and help prevent infection in health care workers. A White House official said the two countries would collaborate on research into its use.

Gallery: How the coronavirus is being handled globally (Photo Services)

Early in the pandemic, the drug's use was spurred by anecdotal reports from China and France of patients who seemed to improve and laboratory findings of a possible antiviral effect. With no proven treatment for Covid-19, doctors have been desperate to give severely ill patients some kind of therapy.

But several studies on sick patients, without control groups, have found no benefit and even possible harm from the drug. A recent Lancet study reported increased risks of heart problems and death. Shortly after it was published, the World Health Organization suspended trials of the drug.

But the Lancet data has been called into question. On Wednesday, the World Health Organization said it would resume the trials it had suspended.

Dr. Soumya Swaminathan, the deputy director of the W.H.O., said, “As of now, there is no evidence that any drug actually reduces the mortality in patients who have Covid-19, and in fact it is an urgent priority for all of us to do the needed studies, to do the randomized clinical trials in order to get that evidence as quickly as possible.”

a man and a woman looking at the camera: Researchers at the University of Minnesota working with coronavirus samples during a study of hydroxychloroquine in March. © Craig Lassig/Reuters Researchers at the University of Minnesota working with coronavirus samples during a study of hydroxychloroquine in March.

Interest in the drug surged after Mr. Trump began advocating it. It is approved to treat rheumatoid arthritis and lupus, as well as malaria, and is considered safe for those patients as long as they do not have underlying abnormalities in their heart rhythm.

Studies in very ill coronavirus patients have linked the drug — especially when combined with the antibiotic azithromycin — to dangerous heart-rhythm disorders, and both the Food and Drug Administration and the National Institute of Allergy and Infectious Diseases have warned that it should not be used outside of clinical trials or carefully monitored conditions in a hospital.

Some researchers say that safety concerns about the drug have been overblown, alarming the public and making it difficult to recruit participants for the studies needed to determine whether the drug has any value for treatment or prevention.

The new study included 821 people from across the United States and parts of Canada who had a either a high-risk or moderate-risk exposure to a person who had tested positive and was ill from the coronavirus. None of the participants had symptoms themselves. High-risk exposure meant they were less than six feet from a patient for more than ten minutes, with neither a mask nor a face shield. Moderate risk meant they wore a mask, but no face shield.

About 88 percent had high-risk exposures.

Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, speaks during the 147th session of the WHO Executive Board session in Geneva, Switzerland, Friday, May 22,2020. (WHO/Christopher Black via AP) © ASSOCIATED PRESS Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, speaks during the 147th session of the WHO Executive Board session in Geneva, Switzerland, Friday, May 22,2020. (WHO/Christopher Black via AP)

The participants, recruited online, ranged in age from 33 to 50, with a median age of 40. About half were women, and 66 percent of the total were health care workers. They were healthy and had no underlying health problems that would have made hydroxychloroquine dangerous for them. Most of the rest had been exposed at home, to an infected spouse, partner or parent.

Within four days of exposure, the participants were picked at random to receive either hydroxychloroquine or a placebo, and then followed to determine whether they had either laboratory-confirmed Covid-19, or an illness consistent with the virus, during the next 14 days.

The drug or placebos were mailed to them, and they then reported their symptoms online to the researchers, who did not examine them.

Not all the participants could be tested for the virus, because when the study was being conducted, there was still a shortage of test kits.

There was no meaningful difference between the placebo group and those who took the drug. Among those taking hydroxychloroquine, 49 of 414, or 11.8 percent, became ill. In the placebo group, 58 or 407, or 14.3 percent, became ill. Analyzed statistically, the difference between those rates was not significant.

Indonesian fire fighters spray disinfectant at a business center on the last day of the lockdown amid the COVID-19 coronavirus pandemic in Jakarta on June 4, 2020. (Photo by ADEK BERRY / AFP) (Photo by ADEK BERRY/AFP via Getty Images) Indonesian fire fighters spray disinfectant at a business center on the last day of the lockdown amid the COVID-19 coronavirus pandemic in Jakarta on June 4, 2020. (Photo by ADEK BERRY / AFP) (Photo by ADEK BERRY/AFP via Getty Images)

The drug also did not make the illness any less severe.

Side effects like nausea from hydroxychloroquine were more common than from placebos, 40.1 percent compared with 16.8 percent, but there were no problems with heart rhythm or any other serious adverse effects.

Infectious disease experts who were not part of the study said it was well done and answered an important question, though the results were disappointing.

Dr. William Schaffner, an infectious disease specialist at Vanderbilt University, said: “This was a large, randomized controlled trial done by very good people. Hydroxychloroquine did not provide a notable advantage.”

Noting that the drug had shown some ability to prevent the virus from infecting cells in laboratory studies, Dr. Schaffner said, “Unfortunately that did not translate into a beneficial effect in preventing the development of illness.”

Migrants from Africa, Cuba and Haiti who are stranded in Honduras after borders were closed due to the coronavirus (COVID-19) pandemic, board a bus going towards to a shelter, during their trek northward in an attempt to reach the U.S., in Tegucigalpa, Honduras June 3, 2020. REUTERS/Jorge Cabrera © Thomson Reuters Migrants from Africa, Cuba and Haiti who are stranded in Honduras after borders were closed due to the coronavirus (COVID-19) pandemic, board a bus going towards to a shelter, during their trek northward in an attempt to reach the U.S., in Tegucigalpa, Honduras June 3, 2020. REUTERS/Jorge Cabrera

An editorial accompanying the study pointed out some limitations: the lack of testing made it impossible to know for sure how many participants actually had Covid-19, and only 75 percent in the hydroxychloroquine group took the full course (some quit because of side effects). In addition, waiting four days after exposure to begin taking the drug may not have given it a chance to work, and starting it earlier might have had a different result.

The editorialist, Dr. Myron S. Cohen from the University of North Carolina, called the results more provocative than definitive, and wrote, “the potential prevention benefits of hydroxychloroquine remain to be determined.”

The study did not address the question of whether hydroxychloroquine can prevent coronavirus infection if people take it before they are exposed to sick patients. That possibility is being studied in other clinical trials involving health care workers and emergency medical technicians and other emergency medical workers.

At a Senate hearing on the F.D.A.’s oversight of foreign drug manufacturing on Tuesday, Democrats criticized the agency for its decision in March to give an emergency use authorization to hydroxychloroquine.

“The F.D.A., in my view, bowed to the pressure and issued what’s called an ‘emergency use authorization’ for the drug,” said Sen. Ron Wyden of Oregon, the ranking Democrat on the Senate Committee on Finance, which sponsored the hearing. “Doing so threw open the door to tens of millions of pills, including some, directly related to this hearing, manufactured inside facilities in Pakistan and India that have either failed F.D.A.’s inspection or never been inspected by the F.D.A. at all.”

Jeremy Kahn, an F.D.A. spokesman, said the agency has done nine “mission-critical” drug facility inspections, including overseas and domestic, since March. But he did not say whether they involved hydroxychloroquine. He also said the agency would not resume regular overseas inspections until the State Department has given the go-ahead for travel.

Sheila Kaplan contributed reporting.

________________________________________

Stay at home as much as possible to stop coronavirus spreading - here is the latest government guidance. If you think you have the virus, don't go to the GP or hospital, stay indoors and get advice online. Only call NHS 111 if you cannot cope with your symptoms at home; your condition gets worse; or your symptoms do not get better after seven days. In parts of Wales where 111 isn't available, call NHS Direct on 0845 46 47. In Scotland, anyone with symptoms is advised to self-isolate for seven days. In Northern Ireland, call your GP.

Coronavirus and you: Supporting mental health through lockdown and beyond

Thrilling treasure finds from the last decade .
From stolen crown jewels and tennis ball-sized diamonds to Winston Churchill's top hat and cigar, there have been some very exciting, and sometimes unusual, treasures discovered over the last decade. Click or scroll through as we look back at 51 of the best treasure finds made between 2010 and 2019, which together span around 56,000 years' worth of human history.

—   Share news in the SOC. Networks
usr: 5
This is interesting!